샘플 요청 목록

 카트 문의
시장보고서
상품코드
1514109

알레르기 치료 시장

Allergy Treatment
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 148 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

알레르기 치료 시장은 2030년까지 241억 달러에 달할 전망입니다.

2023년에 186억 달러로 평가된 알레르기 치료 시장은 분석 기간에 복합 연간 성장률(CAGR) 3.8%로 성장하고 2030년에는 241억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 천식 치료는 복합 연간 성장률(CAGR) 4.3%로 성장을 지속하고, 분석 기간 종료 시 59억 달러에 달할 것으로 예측됩니다. 비염 치료 부문의 성장률은 분석 기간 동안 복합 연간 성장률(CAGR) 4.6%로 추정됩니다.

미국 시장은 50억 달러로 추정되며 중국은 복합 연간 성장률(CAGR) 6.6%로 성장할 것으로 예측됩니다.

미국 알레르기 치료 시장은 2023년 50억 달러로 평가되었습니다. 세계 2위 경제대국인 중국은 2030년까지 50억 달러 규모에 이를 것으로 예측되며, 예측 기간 동안 복합 연간 성장률(CAGR) 6.6%입니다. 다른 주목할만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 복합 연간 성장률(CAGR) 각각 0.9%와 4.4%로 예측되고 있습니다. 유럽에서는 독일이 복합 연간 성장률(CAGR) 1.8%로 성장할 것으로 예측됩니다.

알레르기 치료 - 주요 동향 및 촉진요인

알레르기 치료는 세계 알레르기 질환의 유병률 증가에 대응하고 현대 의료에서 점점 더 필수적입니다. 알레르기는 꽃가루, 음식, 반려동물 비듬과 같은 물질에 대한 과민한 면역 반응으로, 가벼운 불편함에서 심각한 아나필락시스에 이르기까지 광범위한 증상을 일으켜 수백만 명의 사람들에게 영향을 미칩니다. 알레르기의 주요 유형은 호흡기 알레르기(꽃가루 알레르기와 천식 등), 음식 알레르기, 피부 알레르기(습진 등), 벌레 물린 알레르기 등입니다. 치료법은 알레르기 유형과 중증도에 따라 다르며 약물 치료, 면역 요법, 생활 습관 개선 등이 있습니다. 항히스타민제, 부신피질스테로이드제, 충혈제거제, 류코트리엔 억제제 등이 증상의 관리에 일반적으로 사용되며, 피하주사나 설하정 등의 면역요법은 특정 알레르겐에 대한 면역계를 감감작 함으로써 장기적인 완화를 가져옵니다. 이러한 치료법의 효능은 알레르기 관리를 더욱 달성할 수 있게 하여 많은 환자들의 삶의 질을 향상시키고 있습니다.

알레르기 치료의 중요한 동향은 표적 생물학적 제제의 개발이며 심각한 알레르기 증상을 관리하기 위한 보다 개별화된 접근법을 설명합니다. 단클론항체와 같은 생물학적 제제는 알레르기 반응에 관여하는 면역계의 성분을 특이적으로 표적으로서 작용합니다. 예를 들어 심한 천식과 만성 두드러기의 치료에 사용되는 단클론항체인 오말리주맙은 알레르기 반응의 주요 담당자인 면역글로불린 E(IgE)를 표적으로 하고 있습니다. 이러한 고급 치료는 전통적인 치료로 충분한 효과를 얻지 못하는 환자에게 특히 유용합니다. 또한 알레르겐에 대한 노출을 최소화하기 위해 알레르겐 회피 전략, 공기 청정기 및 저 알레르기 제품의 사용과 같은 비 약리학 적 개입이 중요 해지고 있습니다. 성분분해진단법 등의 진단기술의 진보에 의해 알레르겐 감수성을 보다 정확하게 동정할 수 있게 되어, 주문제작의 치료계획이 가능하게 되었습니다. 또한, 원격의료가 알레르기 진료에 통합됨으로써, 특히 원격지나 충분한 진료를 받지 않은 지역에서 전문의에 의한 진찰이나 계속적인 관리에의 액세스가 개선되었습니다.

알레르기 치료 시장의 성장은 알레르기 질환의 유병률 증가, 생물학적 치료의 진보, 알레르기 관리에 대한 의식 증가 등 여러 요인에 의해 야기됩니다. 환경오염, 라이프스타일 변화, 유전적 소인 등의 요인에 영향을 주는 알레르기의 이환율 증가는 효과적인 치료에 대한 수요 증가로 이어지고 있습니다. 의약품 개발의 기술적 진보는 심각한 알레르기에 적극적인 완화를 제공하는 혁신적인 생물학적 요법의 채용을 촉진하고 치료 옵션을 확대하고 있습니다. 알레르기의 조기 진단과 예방적 관리의 중요성에 대한 의식 증가는 더 많은 사람들이 의사의 진단을 받고 치료 요법을 준수하도록 촉구합니다. 또한 의료 인프라가 확대되고 시판되는 알레르기 치료를 이용할 수 있게 됨으로써 알레르기 치료가 더욱 친숙해졌습니다. 또한, 원격 의료 및 디지털 건강 솔루션의 채용이 증가하고 있는 것도 환자의 치료에 대한 액세스를 향상시키고 치료의 어드히어런스를 개선함으로써 시장 성장에 기여하고 있습니다. 이러한 요인은 종합적으로 알레르기 치료 시장의 견조한 성장을 뒷받침하고 알레르기 질환의 더 나은 관리와 환자 결과의 개선을 보장합니다.

조사 대상 기업 예(주목의 12사)

  • ALK-Abello A/S
  • Allergan PLC
  • ALLERGOPHARMA GmbH & Co. KG
  • Allergy Therapeutics plc
  • Genentech, Inc.
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Sanofi SA
  • Stallergenes Greer

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

BJH 24.07.25

Global Allergy Treatment Market to Reach US$24.1 Billion by 2030

The global market for Allergy Treatment estimated at US$18.6 Billion in the year 2023, is expected to reach US$24.1 Billion by 2030, growing at a CAGR of 3.8% over the analysis period 2023-2030. Asthma Treatment, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$5.9 Billion by the end of the analysis period. Growth in the Rhinitis Treatment segment is estimated at 4.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$5.0 Billion While China is Forecast to Grow at 6.6% CAGR

The Allergy Treatment market in the U.S. is estimated at US$5.0 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$5.0 Billion by the year 2030 trailing a CAGR of 6.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.9% and 4.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.8% CAGR.

Allergy Treatment - Key Trends and Drivers

Allergy treatment has become increasingly essential in modern healthcare, addressing the rising prevalence of allergic conditions worldwide. Allergies, which are hypersensitive immune responses to substances such as pollen, food, or pet dander, affect millions of individuals, causing symptoms ranging from mild discomfort to severe anaphylaxis. The primary types of allergies include respiratory allergies (such as hay fever and asthma), food allergies, skin allergies (such as eczema), and insect sting allergies. Treatment options vary depending on the type and severity of the allergy and include medications, immunotherapy, and lifestyle modifications. Antihistamines, corticosteroids, decongestants, and leukotriene inhibitors are commonly used to manage symptoms, while immunotherapy, including subcutaneous injections and sublingual tablets, offers long-term relief by desensitizing the immune system to specific allergens. The effectiveness of these treatments has made managing allergies more attainable, improving the quality of life for many patients.

A significant trend in allergy treatment is the development of targeted biologic therapies, which offer a more personalized approach to managing severe allergic conditions. Biologics, such as monoclonal antibodies, work by specifically targeting components of the immune system involved in allergic reactions. For instance, omalizumab, a monoclonal antibody used in the treatment of severe asthma and chronic urticaria, targets immunoglobulin E (IgE), a key player in allergic responses. These advanced treatments are particularly beneficial for patients who do not respond adequately to traditional therapies. Additionally, there is a growing emphasis on non-pharmacological interventions, including allergen avoidance strategies and the use of air purifiers and hypoallergenic products, to minimize exposure to allergens. Advances in diagnostic techniques, such as component-resolved diagnostics, enable more precise identification of allergen sensitivities, allowing for tailored treatment plans. The integration of telemedicine in allergy care has also improved access to specialist consultations and ongoing management, particularly in remote or underserved areas.

The growth in the allergy treatment market is driven by several factors, including the increasing prevalence of allergic conditions, advancements in biologic therapies, and the rise in awareness about allergy management. The rising incidence of allergies, influenced by factors such as environmental pollution, lifestyle changes, and genetic predisposition, has led to greater demand for effective treatments. Technological advancements in drug development have facilitated the introduction of innovative biologic therapies that provide targeted relief for severe allergies, expanding treatment options. Growing awareness about the importance of early diagnosis and proactive management of allergies has prompted more individuals to seek medical advice and adhere to treatment regimens. Furthermore, the expansion of healthcare infrastructure and the availability of over-the-counter allergy medications have made allergy treatments more accessible. The increasing adoption of telemedicine and digital health solutions is also contributing to market growth by enhancing patient access to care and improving treatment adherence. These factors collectively drive the robust growth of the allergy treatment market, ensuring better management of allergic conditions and improved patient outcomes.

Select Competitors (Total 12 Featured) -

  • ALK-Abello A/S
  • Allergan PLC
  • ALLERGOPHARMA GmbH & Co. KG
  • Allergy Therapeutics plc
  • Genentech, Inc.
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Sanofi SA
  • Stallergenes Greer

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Allergy Treatment - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Allergic Conditions Expands Addressable Market Opportunity for Allergy Treatments
    • Advances in Biologic Therapies Propel Growth in Allergy Treatment Options
    • Increasing Adoption of Personalized Medicine Throws the Spotlight on Tailored Allergy Treatments
    • Development of Targeted Monoclonal Antibodies Strengthens Business Case for Innovative Therapies
    • Growing Use of Non-Pharmacological Interventions Drives Adoption of Allergen Avoidance Strategies
    • Advancements in Diagnostic Techniques Propel Precision in Allergy Identification and Treatment
    • Integration of Telemedicine in Allergy Care Expands Market Reach and Enhances Access to Specialists
    • Rising Awareness about Allergy Management Generates Demand for Early Diagnosis and Treatment
    • Increasing Availability of Over-the-Counter Allergy Medications Drives Consumer Adoption
    • Influence of Environmental Pollution and Lifestyle Changes Propels Demand for Effective Allergy Treatments
    • Adoption of Digital Health Solutions and Mobile Health Apps Generates Opportunities for Enhanced Patient Care
    • Growing Emphasis on Preventive Healthcare Expands Market Potential for Allergy Treatments
    • Rising Incidence of Food Allergies Spurs Demand for Specialized Allergy Treatments
    • Advances in Air Purification Technologies Enhance Market for Allergen Avoidance Products
    • Consumer Preference for Hypoallergenic Products Drives Growth in Allergy Treatment Market
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Allergy Treatment Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Allergy Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Allergy Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Allergy Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Asthma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Asthma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Asthma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Rhinitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Rhinitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Rhinitis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Skin Allergy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Skin Allergy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Skin Allergy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Food Allergy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Food Allergy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Food Allergy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Eye Allergy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Eye Allergy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Eye Allergy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Anti-Allergy Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Anti-Allergy Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Anti-Allergy Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Immunotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Immunotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Immunotherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Oral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Intranasal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Intranasal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Intranasal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Inhalers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Inhalers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: World 16-Year Perspective for Inhalers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Other Dosage Forms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Other Dosage Forms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: World 16-Year Perspective for Other Dosage Forms by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Allergy Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: USA 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Canada 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
  • JAPAN
    • Allergy Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Japan 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
  • CHINA
    • Allergy Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: China 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: China 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: China 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
  • EUROPE
    • Allergy Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Allergy Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Allergy Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Allergy Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Europe 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
  • FRANCE
    • Allergy Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 89: France Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: France 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: France 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: France 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
  • GERMANY
    • Allergy Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Germany 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Germany 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Italy 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Italy 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Allergy Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 116: UK Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: UK 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: UK 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Spain 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Spain 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 131: Spain Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Spain Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Spain 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Russia 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Russia 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 140: Russia Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Russia Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Russia 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Rest of Europe 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Rest of Europe 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Rest of Europe Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Rest of Europe 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Allergy Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Allergy Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Allergy Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Asia-Pacific 16-Year Perspective for Allergy Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Asia-Pacific 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Asia-Pacific 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Asia-Pacific 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Allergy Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Australia 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Australia 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 170: Australia Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Australia Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Australia 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
  • INDIA
    • Allergy Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 173: India Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: India 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: India 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 179: India Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: India Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: India 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: South Korea 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: South Korea 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 188: South Korea Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: South Korea Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: South Korea 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Asia-Pacific Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Asia-Pacific 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Allergy Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Allergy Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Allergy Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Latin America 16-Year Perspective for Allergy Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Latin America 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Latin America 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 209: Latin America Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Latin America Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Latin America 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: Argentina 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 217: Argentina 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 218: Argentina Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Argentina Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 220: Argentina 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 223: Brazil 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 226: Brazil 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 227: Brazil Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 228: Brazil Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 229: Brazil 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 232: Mexico 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 235: Mexico 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 236: Mexico Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 237: Mexico Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 238: Mexico 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 241: Rest of Latin America 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 244: Rest of Latin America 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 246: Rest of Latin America Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 247: Rest of Latin America 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Allergy Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Allergy Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Allergy Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 250: Middle East 16-Year Perspective for Allergy Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 253: Middle East 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 256: Middle East 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 257: Middle East Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 258: Middle East Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 259: Middle East 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 262: Iran 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 265: Iran 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 266: Iran Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 267: Iran Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 268: Iran 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 271: Israel 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 274: Israel 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 275: Israel Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 276: Israel Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 277: Israel 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 280: Saudi Arabia 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 283: Saudi Arabia 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 285: Saudi Arabia Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 286: Saudi Arabia 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 289: UAE 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 292: UAE 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 293: UAE Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 294: UAE Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 295: UAE 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 298: Rest of Middle East 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 301: Rest of Middle East 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 303: Rest of Middle East Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 304: Rest of Middle East 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030
  • AFRICA
    • Allergy Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Allergy Treatment by Type - Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 307: Africa 16-Year Perspective for Allergy Treatment by Type - Percentage Breakdown of Value Sales for Asthma, Rhinitis, Skin Allergy, Food Allergy, Eye Allergy and Other Types for the Years 2014, 2024 & 2030
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Allergy Treatment by Treatment - Anti-Allergy Drugs and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 310: Africa 16-Year Perspective for Allergy Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Allergy Drugs and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 311: Africa Recent Past, Current & Future Analysis for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 312: Africa Historic Review for Allergy Treatment by Dosage Form - Oral, Intranasal, Inhalers and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 313: Africa 16-Year Perspective for Allergy Treatment by Dosage Form - Percentage Breakdown of Value Sales for Oral, Intranasal, Inhalers and Other Dosage Forms for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제